22Serious

Biotechnology

Ask VT AI

View News Summary

Police drop investigation into Kneecap's politically charged Glastonbury performance, citing insufficient evidence, as the band criticizes the process as 'political policing' and 'state intimidation'.
Biden aides refuse to testify on president's mental fitness and classified documents, raising concerns of a cover-up.
Cubs sign veteran pitcher Spencer Turnbull to minor league deal, hoping for a bounce-back performance.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News

Biotechnology, Biotech

NKGen Biotech, HekaBio Partner to Develop NK Cell Therapy in Japan

100% left coverage1 source

Biotechnology, Biotech

NKGen Biotech, HekaBio Partner to Develop NK Cell Therapy in Japan

100% left coverage1 source

NKGen Biotech, HekaBio Partner to Develop NK Cell Therapy in Japan

NKGen Biotech, HekaBio Partner to Develop NK Cell Therapy in Japan

CAR-T Cell Therapy Advances Highlight Rare Tumors, Relapse Challenges

CAR-T Cell Therapy Advances Highlight Rare Tumors, Relapse Challenges

CAR-T Cell Therapy Advances Highlight Rare Tumors, Relapse Challenges

CAR-T Cell Therapy Advances Highlight Rare Tumors, Relapse Challenges

MiNK Therapeutics Reports Complete Remission in Metastatic Testicular Cancer Patient

100% left coverage2 sources

MiNK Therapeutics Reports Complete Remission in Metastatic Testicular Cancer Patient

100% left coverage2 sources

MiNK Therapeutics Reports Complete Remission in Metastatic Testicular Cancer Patient

MiNK Therapeutics Reports Complete Remission in Metastatic Testicular Cancer Patient

Biotechnology, CRISPR

CRISPR Center Launches with $20M to Develop Personalized Therapies

100% left coverage2 sources

Biotechnology, CRISPR

CRISPR Center Launches with $20M to Develop Personalized Therapies

100% left coverage2 sources

CRISPR Center Launches with $20M to Develop Personalized Therapies

CRISPR Center Launches with $20M to Develop Personalized Therapies

Biotechnology, CRISPR

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

100% left coverage1 source

Biotechnology, CRISPR

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

100% left coverage1 source

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

Biotechnology, CRISPR

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

100% left coverage1 source

Biotechnology, CRISPR

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

100% left coverage1 source

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

CRISPR Therapeutics Reports Promising Phase 1 Cardiovascular Trial Results

Stem Cell Therapy Cures 10 of 12 Severe Diabetes Patients

50% left coverage2 sources

Stem Cell Therapy Cures 10 of 12 Severe Diabetes Patients

50% left coverage2 sources

Stem Cell Therapy Cures 10 of 12 Severe Diabetes Patients

Stem Cell Therapy Cures 10 of 12 Severe Diabetes Patients

Ask VT AI

View News Summary

Police drop investigation into Kneecap's politically charged Glastonbury performance, citing insufficient evidence, as the band criticizes the process as 'political policing' and 'state intimidation'.
Biden aides refuse to testify on president's mental fitness and classified documents, raising concerns of a cover-up.
Cubs sign veteran pitcher Spencer Turnbull to minor league deal, hoping for a bounce-back performance.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from Biotechnology